We are live on
!
Find out more
BG
Bollard Group Portfolio holdings
AUM
$3.39B
1-Year Est. Return
1.06%
This Fund
S&P 500
This Quarter
Est. Return
-1.19%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$4.26B
AUM Growth
-$118M
(-2.7%)
Cap. Flow
+$932M
Cap. Flow
% of AUM
21.89%
Top 10 Holdings %
Top 10 Hldgs %
73.27%
Holding
299
New
5
Increased
187
Reduced
15
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$4.87M |
| 2 |
Southern Copper
SCCO
|
+$4.86M |
| 3 |
Oneok
OKE
|
+$3.88M |
| 4 |
Microsoft
MSFT
|
+$3.87M |
| 5 |
Enterprise Products Partners
EPD
|
+$3.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$35.8M |
| 2 |
Eli Lilly
LLY
|
+$32.9M |
| 3 |
Gartner
IT
|
+$18.4M |
| 4 |
BioNTech
BNTX
|
+$2.75M |
| 5 |
Entegris
ENTG
|
+$1.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 51.19% |
| 2 | Technology | 7.33% |
| 3 | Energy | 7.29% |
| 4 | Utilities | 4.99% |
| 5 | Consumer Discretionary | 4.98% |
Similar funds
BCM
OAM
MCM
DFO
VFCM
EFM
WS
DIA
Bollard Group's Q3 2025 Portfolio in Review
As of Q3 2025, Bollard Group held 299 positions worth $4.26B, down 2.7% from $4.37B the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Bollard Group deployed $932M of net new capital in Q3 2025, opening 5 new positions and adding to 187 existing holdings. Its largest new stake was Tortoise North American Pipeline ETF: 68,861 shares worth $2.51M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 56% a quarter earlier, followed by Technology and Energy.
On the sell side, the largest reduction was Boston Scientific, an estimated $35.8M trimmed.
- Bollard Group's largest Q3 2025 buy was Tortoise North American Pipeline ETF: 68,861 shares worth $2.51M.
- Bollard Group added most to Caterpillar in Q3 2025, an estimated $4.87M increase.
- Bollard Group's biggest Q3 2025 reduction was Boston Scientific, cutting an estimated $35.8M.
- Bollard Group fully exited BioNTech in Q3 2025, selling an estimated $2.75M.
- Bollard Group's ten largest holdings make up 73% of its $4.26B portfolio in Q3 2025.
- Bollard Group opened 5 new positions and closed 28 in Q3 2025.
- Bollard Group's portfolio value fell 2.7% quarter-over-quarter to $4.26B.
Based on Bollard Group's 13F filing for Q3 2025, filed 14 Nov 2025.